PUBLISHER: Grand View Research | PRODUCT CODE: 1771572
PUBLISHER: Grand View Research | PRODUCT CODE: 1771572
U.S. Aesthetic Injectable Market Size, Share & Trends Analysis Report By Product (Hyaluronic Acid, Botulinum Toxin), By Application, By End-use, And Segment Forecasts, 2025 - 2030
U.S. Aesthetic Injectable Market Trends:
The U.S. aesthetic injectable market size was estimated at USD 4.1 billion in 2024 and is projected to grow at a CAGR of 11.2% from 2025 to 2030. The U.S. aesthetic injectable industry continues to evolve as consumer expectations shift toward convenience, personalization, and preventative care. The growing popularity of injectables among a broader range of users, along with advances in product design, is changing the way cosmetic treatments are perceived and delivered. In May 2023, Allergan Aesthetics launched Skinvive by Juvederm in the U.S., an intradermal HA-based microdroplet injection designed to improve cheek skin quality by enhancing hydration and smoothness.
A strong preference for non-surgical cosmetic solutions drives the U.S. aesthetic injectable industry. Consumers are increasingly choosing injectables due to their convenience, short recovery time, and ability to deliver natural-looking results. These procedures offer a discreet option for facial rejuvenation without the risks or downtime associated with surgery. The appeal of quick treatments with visible enhancements fits nicely into the lifestyle of professionals and younger individuals seeking subtle improvements. According to the American Society of Plastic Surgeons (ASPS) 2023 data, 1.47 million cosmetic minimally invasive procedures were performed on males, including 526,062 neuromodulator injections and over 232,000 filler treatments. For females, the number reached 19.7 million, with 8.2 million neuromodulator injections and over 5.5 million filler procedures.
Injectable treatments are growing in popularity among men and younger consumers, who view them not just as corrective tools but as a form of proactive self-care. Men are turning to injectables to refine facial features, while individuals in their 20s and 30s often use them to prevent early signs of aging. This shifting demographic has broadened the customer base and encourages providers to tailor services and messaging to a more diverse audience, including those looking for maintenance rather than transformation. In October 2024, Allergan Aesthetics presented new data at the ASDS Annual Meeting in Orlando, Florida, highlighting safety and patient satisfaction with facial injectables. The presentations included diverse patient demographics across the U.S., emphasizing treatment efficacy and social media's impact on patient expectations.
Ongoing innovation is shaping the competitive edge of the injectable market. New products are designed to last longer, integrate more seamlessly with skin, and provide more natural movement and appearance. These advancements make treatments more appealing to first-time users and returning clients. With the development of differentiated formulations and targeted applications, brands can address specific aesthetic concerns with greater precision and reliability. In January 2025, Galderma announced positive interim results from a U.S.-based trial evaluating Sculptra combined with Restylane for treating facial volume loss caused by medication-driven weight loss. The study showed significant aesthetic improvements and high patient satisfaction. A six-month extension is ongoing to assess long-term effects.
U.S. Aesthetic Injectable Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. aesthetic injectable market report based on product, application, and end-use:
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Hyaluronic Acid (HA)
- Botulinum Toxin (Botox)
- Aquatic Light Injections
- Others
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Facial Line Correction
- Lip Augmentation
- Face Lift
- Acne Scar Treatment
- Lipoatrophy Treatment
- Others
- End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical Spas
- Dermatology Clinics
- Hospitals
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Volume price analysis (Model 1)
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End use outlook
- 2.3. Competitive Insights
Chapter 3. U.S. Aesthetic Injectable Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising demand for minimally invasive procedures
- 3.2.1.2. Expanding acceptance among male and younger demographics
- 3.2.1.3. Continuous product innovation and longer-lasting formulations
- 3.2.2. Market restraint analysis
- 3.2.2.1. Restricted availability and practitioner access in suburban and rural areas
- 3.2.2.2. Regulatory constraints and lack of insurance coverage
- 3.2.1. Market driver analysis
- 3.3. U.S. Aesthetic Injectable Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.1. Industry Analysis - Porter's
Chapter 4. U.S. Aesthetic Injectable Market: Product Estimates & Trend Analysis
- 4.1. U.S. Aesthetic Injectable Market: Product Dashboard
- 4.2. U.S. Aesthetic Injectable Market: Product Movement Analysis
- 4.3. U.S. Aesthetic Injectable Market by Product, Revenue
- 4.4. Hyaluronic Acid (HA)
- 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.5. Botulinum Toxin (Botox)
- 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.6. Aquatic Light Injections
- 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.7. Others
- 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. U.S. Aesthetic Injectable Market: Application Estimates & Trend Analysis
- 5.1. U.S. Aesthetic Injectable Market: Application Dashboard
- 5.2. U.S. Aesthetic Injectable Market: Application Movement Analysis
- 5.3. U.S. Aesthetic Injectable Market by Application, Revenue
- 5.4. Facial Line Correction
- 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.5. Lip Augmentation
- 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.6. Face Lift
- 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.7. Acne Scar Treatment
- 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.8. Lipoatrophy Treatment
- 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.9. Others
- 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. U.S. Aesthetic Injectable Market: End Use Estimates & Trend Analysis
- 6.1. U.S. Aesthetic Injectable Market: End Use Dashboard
- 6.2. U.S. Aesthetic Injectable Market: End Use Movement Analysis
- 6.3. U.S. Aesthetic Injectable Market by End Use, Revenue
- 6.4. Medical Spas
- 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 6.5. Dermatology Clinics
- 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 6.6. Hospitals
- 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
- 7.2. Company/Competition Categorization
- 7.2.1. Key company market share analysis, 2024
- 7.3. Company Profiles
- 7.3.1. Ipsen Pharma
- 7.3.1.1. Company overview
- 7.3.1.2. Financial performance
- 7.3.1.3. Product benchmarking
- 7.3.1.4. Strategic initiatives
- 7.3.2. AbbVie, Inc.
- 7.3.2.1. Company overview
- 7.3.2.2. Financial performance
- 7.3.2.3. Product benchmarking
- 7.3.2.4. Strategic initiatives
- 7.3.3. Merz GmbH and Co. KGaA
- 7.3.3.1. Company overview
- 7.3.3.2. Financial performance
- 7.3.3.3. Product benchmarking
- 7.3.3.4. Strategic initiatives
- 7.3.4. Galderma
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. Prollenium Medical Technologies, Inc.
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Tiger Aesthetics Medical, LLC
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Sinclair Pharma
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. Medytox, Inc.
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. Revance Therapeutics, Inc.
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Product benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.1. Ipsen Pharma
List of Tables
- Table 1 List of Abbreviations
- Table 2 U.S. aesthetic injectable market, by product, 2018 - 2030 (USD Million)
- Table 3 U.S. aesthetic injectable market, by application, 2018 - 2030 (USD Million)
- Table 4 U.S. aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
- Table 5 Participant's overview
- Table 6 Financial performance
- Table 7 Key companies undergoing expansions
- Table 8 Key companies undergoing acquisitions
- Table 9 Key companies undergoing collaborations
- Table 10 Key companies launching new services
- Table 11 Key companies undergoing partnerships
- Table 12 Key companies undertaking other strategies
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information procurement
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Market formulation & validation
- Fig. 6 U.S. aesthetic injectable market segmentation
- Fig. 7 Market snapshot, 2024
- Fig. 8 Market trends & outlook
- Fig. 9 Market driver relevance analysis (current & future impact)
- Fig. 10 Market restraint relevance analysis (current & future impact)
- Fig. 11 Swot analysis, by factor (political & legal, economic and technological)
- Fig. 12 Porter's five forces analysis
- Fig. 13 U.S. Aesthetic Injectable Market: Product Outlook Key Takeaways
- Fig. 14 U.S. Aesthetic Injectable Market: Product Movement Analysis
- Fig. 15 Hyaluronic acid (HA) market, 2018 - 2030 (USD Million)
- Fig. 16 Botulinum toxin (Botox) market, 2018 - 2030 (USD Million)
- Fig. 17 Aquatic light injections market, 2018 - 2030 (USD Million)
- Fig. 18 Others market, 2018 - 2030 (USD Million)
- Fig. 19 U.S. aesthetic injectable market: Application outlook key takeaways
- Fig. 20 U.S. aesthetic injectable market: Application movement analysis
- Fig. 21 Facial line correction market, 2018 - 2030 (USD Million)
- Fig. 22 Lip augmentation market, 2018 - 2030 (USD Million)
- Fig. 23 Face lift market, 2018 - 2030 (USD Million)
- Fig. 24 Acne scar treatment market, 2018 - 2030 (USD Million)
- Fig. 25 Lipoatrophy treatment market, 2018 - 2030 (USD Million)
- Fig. 26 Others market, 2018 - 2030 (USD Million)
- Fig. 27 U.S. aesthetic injectable market: End use outlook key takeaways
- Fig. 28 U.S. aesthetic injectable market: End use movement analysis
- Fig. 29 Medical spas market, 2018 - 2030 (USD Million)
- Fig. 30 Dermatology clinics market, 2018 - 2030 (USD Million)
- Fig. 31 Hospitals market, 2018 - 2030 (USD Million)
- Fig. 32 Strategy framework
